SEC Form 4 · accession 0000899243-16-033409
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David L Mahoney
Director
Period of report
Nov 11, 2016
Accepted (ET)
Nov 14, 2016 · 8:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 11, 2016 | M | 30,000 | $2.70 | A | 1,199,320 | I | David L. Mahoney and Winnifred C. Ellis 1998 Family Trust |
| Common Stock | Nov 11, 2016 | S | 30,000 | $9.35 | D | 1,169,320 | I | David L. Mahoney and Winnifred C. Ellis 1998 Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.70 | Nov 11, 2016 | M | 30,000 | D | — | Dec 19, 2017 | Common Stock | 30,000 | 0 | D |
Explanation of responses
- F1Fully exercisable.